Structural and Functional Comparison of the RING Domains of Two p53 E3 Ligases, Mdm2 and Pirh2*
暂无分享,去创建一个
B. Raught | C. Arrowsmith | Y. Sheng | V. Saridakis | Shili Duan | S. Dhe-Paganon | J. Shloush | J. Vlassov | Ian Engson
[1] E. Appella,et al. Control of p53 multimerization by Ubc13 is JNK-regulated , 2009, Proceedings of the National Academy of Sciences.
[2] Tharan Srikumar,et al. Global map of SUMO function revealed by protein-protein interaction and genetic networks. , 2009, Molecular cell.
[3] J. Lukin,et al. Molecular basis of Pirh2-mediated p53 ubiquitylation , 2008, Nature Structural &Molecular Biology.
[4] D. Vaux,et al. Structures of the cIAP2 RING Domain Reveal Conformational Changes Associated with Ubiquitin-conjugating Enzyme (E2) Recruitment* , 2008, Journal of Biological Chemistry.
[5] Yi Tang,et al. Acetylation Is Indispensable for p53 Activation , 2008, Cell.
[6] M. Lei,et al. Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway , 2008, Nature Cell Biology.
[7] D. Vaux,et al. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans , 2008, Cell Death and Differentiation.
[8] P. Brzovic,et al. E2–BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages , 2007, Nature Structural &Molecular Biology.
[9] Michael A. Dyer,et al. MDMX: from bench to bedside , 2007, Journal of Cell Science.
[10] S. Yamasaki,et al. Cytoplasmic destruction of p53 by the endoplasmic reticulum‐resident ubiquitin ligase ‘Synoviolin’ , 2007, The EMBO journal.
[11] A. Kentsis,et al. The Mdm2 RING domain C‐terminus is required for supramolecular assembly and ubiquitin ligase activity , 2007, The EMBO journal.
[12] K. Vousden,et al. An essential function of the extreme C‐terminus of MDM2 can be provided by MDMX , 2007, The EMBO journal.
[13] G. Wahl,et al. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas , 2006, Nature Reviews Cancer.
[14] Laurent Le Cam,et al. E4F1 Is an Atypical Ubiquitin Ligase that Modulates p53 Effector Functions Independently of Degradation , 2006, Cell.
[15] H. Dyson,et al. Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53. , 2006, Journal of molecular biology.
[16] Xin Wu,et al. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells. , 2006, Experimental cell research.
[17] John Calvin Reed,et al. Regulation of p53 Localization and Activity by Ubc13 , 2006, Molecular and Cellular Biology.
[18] C. Robson,et al. Human PIRH2 Enhances Androgen Receptor Signaling through Inhibition of Histone Deacetylase 1 and Is Overexpressed in Prostate Cancer , 2006, Molecular and Cellular Biology.
[19] R. Copeland,et al. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination. , 2006, Biochemistry.
[20] Yi Zhang,et al. Structure of a Bmi-1-Ring1B Polycomb Group Ubiquitin Ligase Complex* , 2006, Journal of Biological Chemistry.
[21] Oliver Weichenrieder,et al. Structure and E3‐ligase activity of the Ring–Ring complex of Polycomb proteins Bmi1 and Ring1b , 2006, The EMBO journal.
[22] G. Wahl,et al. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4 , 2006, Cell Death and Differentiation.
[23] S. Francoz,et al. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[24] O. Myklebost,et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[25] W. Deppert,et al. Transcription-independent pro-apoptotic functions of p53. , 2005, Current opinion in cell biology.
[26] Jun Qin,et al. ARF-BP1/Mule Is a Critical Mediator of the ARF Tumor Suppressor , 2005, Cell.
[27] C. Dominguez,et al. Solution structure of the ubiquitin-conjugating enzyme UbcH5B. , 2004, Journal of molecular biology.
[28] Wei-Guo Zhu,et al. Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer. , 2004, Journal of the National Cancer Institute.
[29] Chris F. Taylor,et al. A common open representation of mass spectrometry data and its application to proteomics research , 2004, Nature Biotechnology.
[30] A. Jochemsen,et al. Mdmx and Mdm2: Brothers in Arms? , 2004, Cell cycle.
[31] Robertson Craig,et al. TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.
[32] Patrick Dowd,et al. The ubiquitin ligase COP1 is a critical negative regulator of p53 , 2004, Nature.
[33] Rolf Boelens,et al. Structural model of the UbcH5B/CNOT4 complex revealed by combining NMR, mutagenesis, and docking approaches. , 2004, Structure.
[34] L. Vassilev,et al. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.
[35] D. Green,et al. p53's Believe It or Not: Lessons on Transcription-Independent Death , 2003, Journal of Clinical Immunology.
[36] A. Lyakhovich,et al. Supramolecular Complex Formation between Rad6 and Proteins of the p53 Pathway during DNA Damage-Induced Response , 2003, Molecular and Cellular Biology.
[37] Guillermina Lozano,et al. Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation , 2003, Cell.
[38] A. Jochemsen,et al. Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53* , 2002, The Journal of Biological Chemistry.
[39] M. Roussel,et al. The RING domain of Mdm2 can inhibit cell proliferation. , 2002, Cancer research.
[40] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[41] D. Woods,et al. C-Terminal Ubiquitination of p53 Contributes to Nuclear Export , 2001, Molecular and Cellular Biology.
[42] M. King,et al. BRCA1 RING Domain Cancer-predisposing Mutations , 2001, The Journal of Biological Chemistry.
[43] N. Little,et al. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms , 2001, EMBO reports.
[44] Rachel E. Klevit,et al. Structure of a BRCA1–BARD1 heterodimeric RING–RING complex , 2001, Nature Structural Biology.
[45] Valerie Reinke,et al. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53 , 2001, Nature Genetics.
[46] A. Weissman. Ubiquitin and proteasomes: Themes and variations on ubiquitylation , 2001, Nature Reviews Molecular Cell Biology.
[47] R. Hay,et al. Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation , 2000, Molecular and Cellular Biology.
[48] Ping Wang,et al. Structure of a c-Cbl–UbcH7 Complex RING Domain Function in Ubiquitin-Protein Ligases , 2000, Cell.
[49] Shengyun Fang,et al. Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53* , 2000, The Journal of Biological Chemistry.
[50] M. Jackson,et al. MdmX Protects p53 from Mdm2-Mediated Degradation , 2000, Molecular and Cellular Biology.
[51] Hirofumi Tanaka,et al. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 , 1997, FEBS letters.
[52] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[53] A. Levine,et al. Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.
[54] M. Billeter,et al. MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.
[55] Lawrence A. Donehower,et al. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.
[56] Guillermina Lozano,et al. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.
[57] C. Sander,et al. Dali: a network tool for protein structure comparison. , 1995, Trends in biochemical sciences.
[58] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[59] P. Freemont,et al. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto‐oncoprotein PML. , 1995, The EMBO journal.
[60] E. Grishin,et al. Three-dimensional structure of ectatomin from Ectatomma tuberculatum ant venom , 1995, Journal of biomolecular NMR.
[61] M. Scheffner,et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.
[62] L. Banks,et al. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. , 1986, European journal of biochemistry.